BV
Bioventus
BVS·NYSEDurham NCFounded 2012800 employees
Small CapbiotechPublicMusculoskeletal
Platform: OA Biologics
Market Cap
$0.3B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (BVS)
Loading BVS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sotovorutinib | BVS-9253 | Phase 2/3 | 1 | AuroraA | AngelmanCeliac | ||
| Elralucimab | BVS-7958 | Phase 1 | 1 | Tau | NMOSDT2D |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)